The combination of urgent need and unprecedented public investment turned the typical R&D process on its head. Now, with pandemic vaccines launching at record speeds, we talk with experts in infectious disease research to examine the lessons learned from the pandemic and how they might change future vaccine development.
We'll seek to answer the questions such as:

How can new vaccine technologies stave off future outbreaks? After COVID, will researchers—and biopharma companies—increase their focus on other known infectious diseases? Will vaccines attract more investment and partnerships?